Umbilical Cord Transplantation: Epilogue

Seminars in Hematology

Volumn 47, Issue 1, 2010, Pages 97-103

  Broxmeyer, Hal E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV;

ARTICLE; CELL FUNCTION; CELL HOMING; CELL POPULATION; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYONIC STEM CELL; ENGRAFTMENT; EX VIVO STUDY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; PLACENTA PERFUSION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL;

ANIMALS; CORD BLOOD STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; TRANSLATIONAL RESEARCH; TREATMENT OUTCOME;

EID: 72449162691     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2009.10.002     Document Type: Article

References (83)

1. Broxmeyer H.E. Cord blood transplantation: a mini review celebrating the 20th anniversary of the first cord blood transplant. Hematologist 6 (2009) 7
2. Broxmeyer H.E., Douglas G.W., Hangoc G., Cooper S., Bard J., English D., et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 86 (1989) 3828-3832
3. Broxmeyer H.E., Kurtzberg J., Gluckman E., Auerbach A.D., Douglas G., Cooper S., et al. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells 17 (1991) 313-329
4. Gluckman E., Broxmeyer H.E., Auerbach A.D., Friedman H., Douglas G.W., Devergie A., et al. Hematopoietic reconstitution in a patient with Fanconi anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321 (1989) 1174-1178
5. Broxmeyer H.E. Introduction: Past, present and future of cord blood transplantation. In: Broxmeyer H.E. (Ed). Cellular characteristics of cord blood and cord blood transplantation (1997), American Association of Blood Banking, Bethesda, MD 1-11
6. Broxmeyer H.E. Introduction. Cord blood transplantation: looking back and to the future. In: Cohen S.B.A., Gluckman E., Rubinstein P., and Madrigal J.A. (Eds). Cord blood characteristics: role in stem cell transplantation (2000), Dunitz, London 1-12
7. Broxmeyer H.E., and Smith F.O. Cord blood hematopoietic cell transplantation. In: Appelbaum F.R., Forman S.J., Negrin R.S., and Blume K.G. (Eds). Thomas' hematopoietic cell transplantation. 4th ed. (2009), Wiley-Blackwell, West Sussex, UK 559-576
8. Laughlin M.J., Eapen M., Rubinstein P., Wagner J.E., Zhang M.-J., Champlin R.E., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351 (2004) 2265-2275
9. Kurtzberg J., Prasad V.K., Carter S.L., Wagner J.E., Baxter-Lowe L.A., Wall D., et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 112 (2008) 4318-4327
10. Sauter C., and Barker J.N. Unrelated donor umbilical cord blood transplantation for the treatment of hematologic malignancies. Curr Opin Hematol 15 (2008) 568-575
11. Advani A.S., and Laughlin M.J. Umbilical cord blood transplantation for acute myeloid leukemia. Curr Opin Hematol 16 (2009) 124-128
12. Atsuta Y., Suzuki R., Nagamura-Inoue T., Taniguchi S., Takahashi S., Kai S., et al. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood 113 (2009) 1631-1638
13. Gluckman E., Rocha V., Ionescu I., Bierings M., Harris R.E., Wagner J., et al. Results of unrelated cord blood transplant in Fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 13 (2007) 1073-1082
14. Yoshimi A., Kojima S., Taniguchi S., Hara J., Matsui T., Takahashi Y., et al. Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant 14 (2008) 1057-1063
15. Parikh S.H., Mendizabal A., Martin P.L., Prasad V.K., Szabolcs P., Driscoll T.A., et al. Unrelated donor umbilical cord blood transplantation in pediatric myelodysplastic syndrome: a single-center experience. Biol Blood Marrow Transplant 15 (2009) 948-955
16. Prasad V.K., Mendizabal A., Parikh S.H., Szabolcs P., Driscoll T.A., and Page K. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 112 (2008) 2979-2989
17. Brunstein C.G., Barker J.N., Weisdorf D.J., DeFor T.E., Miller J.S., Blazar B.R., et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 deaths with hematologic disease. Blood 110 (2007) 3064-3070
18. Uchida T., Wake A., Takagi S., Yamamoto H., Kato D., Matsubashi Y., et al. Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseases. Biol Blood Marrow Transplant 14 (2008) 583-590
19. Brunstein C.G., and Wagner Jr. J.E. Umbilical cord blood transplantation. In: Hoffman R., Benz Jr. E.J., Shattil S.J., Furie B., Silberstein L.E., McGlave P., Heslop H., and Anastasi J. (Eds). Hematology: basic principles and practice. 5th ed. (2009), Elsevier Churchill Livingston, Philadelphia 1643-1664
20. Brunstein C.G., Setubal D.C., and Wagner J.E. Expanding the role of umbilical cord blood transplantation. Br J Haematol 137 (2007) 20-35
21. Fernandes J., Rocha V., Robin M., Peffault de Latour R., Traineau R., Devergie A., et al. Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation. Br J Haematol 137 (2007) 248-251
22. Hayani A., Lampeter E., Viswanatha D., Morgan D., and Salvi S.N. First report of autologous cord blood transplantation in the treatment of a child with leukemia. Pediatrics 119 (2007) e296-e300
23. Nietfeld J.J., Marcelo C., Pasquini M.C., Logan B.R., Verter F., and Horowitz M.M. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Biol Blood Marrow Transplant 14 (2008) 316-322
24. Majeti R., Park C.Y., and Weissman I.L. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 1 (2007) 635-645
25. Weissman IL, Shizuru JA. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood. 112:3543-53.
26. Tao W., and Broxmeyer H.E. Towards a molecular understanding of hematopoietic stem and progenitor cells. In: Broxmeyer H.E. (Ed). Cord blood: biology, immunology, banking, and clinical transplantation (2004), American Association of Blood Banking, Bethesda, MD 87-123
27. + myeloid cells. Stem Cells 22 (2004) 1003-1014
28. Wu M., Kwon H.Y., Rattis F., Blum J., Zhao C., Ashkenazi R., et al. Imaging hematopoietic precursor division in real time. Cell Stem Cell 1 (2007) 541-554
29. Sakaue-Sawano A., Kurokawa H., Morimura T., Hanyu A., Hama H., Osawa H., et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132 (2008) 487-498
30. Yashiro Y., Bannai H., Minowa T., Yabiku T., Miyano S., Osawa M., et al. Transcriptional profiling of hematopoietic stem cells by high-throughput sequencing. Int J Hematol 89 (2009) 24-33
31. Hills M, Lucke K, Chavez EA, Eaves CJ, Lansdorp PM. Probing the mitotic history and development of hematopoietic cells using single telomere length analysis (STELA). Blood. 113:5765-75.
32. Yamazaki S., and Nakauchi H. Insights into signaling and function of hematopoietic stem cells at the single level. Curr Opin Hematol 16 (2009) 255-258
33. Beckmann J., Scheitza S., Wernet P., Fischer J.C., and Giebel B. Asymmetric cell division within the human hematopoietic stem and progenitor cell compartment: identification of asymmetrically segregating proteins. Blood 109 (2007) 5494-5501
34. Mantel C.R., Wang R.-H., Deng C., and Broxmeyer H.E. Sirt1, Notch, and stem cell "age asymmetry". Cell Cycle 7 (2008) 2821-2825
35. Broxmeyer H.E., Srour E.F., Hangoc G., Cooper S., Anderson J.A., and Bodine D. High efficiency recovery of hematopoietic progenitor cells with extensive proliferative and ex-vivo expansion activity and of hematopoietic stem cells with NOD/SCID mouse repopulation ability from human cord blood stored frozen for 15 years. Proc Natl Acad Sci U S A 100 (2003) 645-650
36. Bornstein R., Flores A.I., Montalban M.A., Del Rey J.J., De La Serna J., and Gilsanz F. A modified cord blood collection method achieves sufficient cell levels for transplantation in most adult patients. Stem Cells 23 (2005) 324-334
37. Broxmeyer H.E., Cooper S., Hass D.M., Hathaway J.K., Stehman F.B., and Hangoc G. Experimental basis of cord blood transplantation. Bone Marrow Transplant (2009) e-pub ahead of print
38. Gekas C., Dieterlen-Lievre F., Orkin S.H., and Mikkola H.K. The placenta is a niche for hematopoietic stem cells. Dev Cell 8 (2005) 365-375
39. Mikkola H.K.A., Gekas C., Orkin S.H., and Dieterlen-Lievre F. Placenta as a site for hematopoietic stem cell development. Exp Hematol 33 (2005) 1048-1054
40. Adams GB, Scadden DT. The hematopoietic stem cell in its place. Nat Immunol. 7:333-7.
41. Spiegel A., Kalinkovich A., Shivtiel S., Kollet O., and Lapidot T. Stem cell regulation via dynamic interactions of the nervous and immune systems with the microenvironment. Cell Stem Cell 3 (2008) 484-492
42. Morrison S.J., and Spradling A.C. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 132 (2008) 598-611
43. Christopherson II K.W., Hangoc G., Mantel C., and Broxmeyer H.E. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305 (2004) 1000-1003
44. + cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice. Stem Cells Dev 16 (2007) 347-354
45. Tian C, Bagley J, Forman D, Iacomini J. Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors. Gene Ther. 13:652-8.
46. Peranteau WH, Endo M, Adibe OO, Merchant A, Zoltick PW, Flake AW. CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. Blood. 108:4268-74.
47. null immunodeficient mice. Stem Cells Dev 16 (2007) 355-360
48. + peripheral blood cells. Stem Cells Dev 16 (2007) 361-370
49. Wyss B.K., Donnelly A.F.W., Zhou D., Sinn A.L., Pollok K., and Goebel W.S. Enhanced homing and engraftment of fresh but not ex vivo cultured murine marrow cells in submyeloablated hosts following CD26 inhibition by diprotin A. Exp Hematol 37 (2009) 814-823
50. North T.E., Goessling W., Walkley C.R., Lengerke C., Kopani K.R., Lord A.M., et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447 (2007) 1007-1011
51. 2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 113 (2009) 5444-5455
52. Broxmeyer H.E. Mechanism unknown: prostaglandin E2 may improve HSC therapies. Cell Stem Cell 1 (2007) 135-136
53. Xia L., McDaniel J.M., Yago T., Doeden A., and McEver R.P. Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow. Blood 104 (2004) 3091-3096
54. αs-mediated signaling to engraft bone marrow. Nature 459 (2009) 103-108
55. - severe combined immunodeficiency-repopulating cells by intra-bone marrow injection. Stem Cells 25 (2007) 1348-1355
56. Inaba M., Adachi Y., Hisha H., Hosaka N., Maki M., Ueda Y., et al. Extensive studies on perfusion method plus intra-bone marrow-bone marrow transplantation using cynomolgus monkeys. Stem Cells 25 (2007) 2098-2103
57. Jung W.C., Beard B.C., Morris J.C., Neff T., Beebe K., Storer B.E., et al. Hematopoietic stem cell engraftment: a direct comparison between intramarrow and intravenous injection in nonhuman primates. Exp Hematol 35 (2007) 1132-1139
58. Shaheen M., and Broxmeyer H.E. The humoral regulation of hematopoiesis. In: Hoffman R., Benz Jr. E.J., Shattil S.J., Furie B., Silberstein L.E., McGlave P., Heslop H., and Anastasi J. (Eds). Hematology: basic principles and practice. 5th ed. (2009), Elsevier Churchill Livingston, Philadelphia 253-275
59. Dahl R., and Hromas R. Transcriptional factors in normal and malignant hematopoiesis. In: Hoffman R., Benz Jr. E.J., Shattil S.J., Furie B., Silberstein L.E., McGlave P., Heslop H., and Anastasi J. (Eds). Hematology: basic principles and practice. 5th ed. (2009), Elsevier Churchill Livingston, Philadelphia 213-230
60. Finkel T., Deng C.-X., and Mostoslavsky R. Recent progress in the biology and physiology of Sirtuins. Nature 460 (2009) 587-591
61. Han M.-K., Song E.K., Guo Y., Ou X., Mantel C., and Broxmeyer H.E. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2 (2008) 241-251
62. Campbell T.B., Basu S., Hangoc G., Tao G., and Broxmeyer H.E. Overexpression of the novel ras related GTPase Rheb2 enhances mouse hematopoietic progenitor cell growth while impairing in vivo stem cell repopulation. Blood 114 (2009) 3392-3401
63. Bianco R., Gehron Robey P., and Simmons P.J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2 (2008) 313-319
64. Uccelli A., Moretta L., and Pistoia V. Mesenchymal stem cells in health and disease. Nature 8 (2008) 726-736
65. Prockop D.J. Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Ther 17 (2009) 939-946
66. Broxmeyer H.E., Srour E., Orschell C., Ingram D.A., Cooper S., Plett P.A., et al. Cord blood hematopoietic stem and progenitor cells. In: Klimanskaya I, Lanza R, editors. Methods Enzymol 419 (2009) 439-473
67. Au P., Daheron L.M., Duda D.G., Cohen K.S., Tyrrell J.A., Lanning R.M., et al. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 111 (2008) 1302-1305
68. Yoder M.C., and Ingram D.A. Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Curr Opin Hematol 16 (2009) 269-273
69. Mund J.A., Ingram D.A., Yoder M.C., and Case J. Endothelial progenitor cells and cardiovascular cell-based therapies. Cytotherapy 11 (2009) 103-113
70. Giarratana M.-C., Kobari L., Lapillonne H., Chalmers D., Kiger L., Cynober T., et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotech 23 (2005) 69-74
71. Migliaccio A.R., Whitsett C., and Migliaccio G. Erythroid cells in vitro: from developmental biology to blood transfusion products. Curr Opin Hematol 16 (2009) 259-268
72. + cells, thrombopoietin-amplified in clinical grade serum-free culture. Exp Hematol 36 (2008) 244-252
73. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
74. Okita K., Ichisaka T., and Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448 (2007) 313-317
75. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluirpotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
76. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from human fibroblasts by defined factors. Cell 131 (2007) 861-872
77. Loh Y.-H., Agarwal S., Park I.-H., Urbach A., Huo H., Heffner G.C., et al. Generation of induced pluripotent stem cells from human blood. Blood 113 (2009) 5476-5479
78. Haase A., Olmer R., Schwanke K., Wunderlich S., Merkert S., Hess C., et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5 (2009) 434-441
79. Ye Z., Zhang H., Mali P., Dowey S., Williams D.M., Jang Y.-Y., et al. Human induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood (2009) e-pub ahead of print
80. Giorgetti A., Montserrat N., Aasen T., Gonzalez F., Rodriguez-Piza I., Vassena R., et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5 (2009) 353-357
81. Park I.-H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., et al. Disease-specific induced pluripotent stem cells. Cell 134 (2008) 877-886
82. Hanna J., Wernig M., Markoulaki S., Sun C.-W., Meissner A., Cassady J.P., et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318 (2007) 1920-1923
83. Yamanaka S. A fresh look at iPS cells. Cell 137 (2009) 13-17